Sanofi-Aventis (France) Study Finds Heart Rhythm Drug Cuts Stroke Risk by 1/3

September 3, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

BRIDGEWATER, N.J. - An experimental drug to treat irregular heart rhythm reduced the risk of stroke by one-third, according to data presented at the European Society of Cardiology conference Wednesday.

Twitter
LinkedIn
Facebook
Email
Print

Clinical research Postmarket research

Sanofi (France)